SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Angiodynamics Inc – ‘10-Q’ for 8/31/16 – ‘R47’

On:  Wednesday, 10/5/16, at 1:31pm ET   ·   For:  8/31/16   ·   Accession #:  1275187-16-37   ·   File #:  0-50761

Previous ‘10-Q’:  ‘10-Q’ on 4/11/16 for 2/29/16   ·   Next:  ‘10-Q’ on 1/6/17 for 11/30/16   ·   Latest:  ‘10-Q’ on 4/9/24 for 2/29/24   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

10/05/16  Angiodynamics Inc                 10-Q        8/31/16   70:4.8M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    383K 
 2: EX-10.1     Material Contract                                   HTML     59K 
 3: EX-10.2     Material Contract                                   HTML     57K 
 4: EX-10.3     Material Contract                                   HTML    115K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     26K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     22K 
15: R1          Document and Entity Information                     HTML     41K 
16: R2          Consolidated Condensed Statements of Income (Loss)  HTML     83K 
                (Unaudited)                                                      
17: R3          Consolidated Condensed Statements of Comprehensive  HTML     48K 
                Income (Loss) (Unaudited)                                        
18: R4          Consolidated Condensed Balance Sheets (Unaudited)   HTML    110K 
19: R5          Consolidated Condensed Balance Sheets (Unaudited)   HTML     44K 
                (Parenthetical)                                                  
20: R6          Consolidated Condensed Statements of Cash Flows     HTML     94K 
                (Unaudited)                                                      
21: R7          Consolidated Condensed Statement of Stockholders'   HTML     72K 
                Equity (Unaudited)                                               
22: R8          Consolidated Condensed Financial Statements         HTML     29K 
23: R9          Inventories                                         HTML     31K 
24: R10         Other Assets                                        HTML     25K 
25: R11         Goodwill and Intangible Assets                      HTML     77K 
26: R12         Accrued Liabilities                                 HTML     35K 
27: R13         Long Term Debt                                      HTML     30K 
28: R14         Income Taxes                                        HTML     43K 
29: R15         Share-Based Compensation                            HTML     30K 
30: R16         Earnings Per Share                                  HTML     33K 
31: R17         Segment and Geographic Information                  HTML     47K 
32: R18         Fair Value                                          HTML    124K 
33: R19         Marketable Securities                               HTML     53K 
34: R20         Commitments and Contingencies                       HTML     43K 
35: R21         Recently Issued Accounting Pronouncements           HTML     37K 
36: R22         Restructuring                                       HTML     24K 
37: R23         Recently Issued Accounting Pronouncements           HTML     33K 
                (Policies)                                                       
38: R24         Inventories (Tables)                                HTML     32K 
39: R25         Goodwill and Intangible Assets (Tables)             HTML     67K 
40: R26         Accrued Liabilities (Tables)                        HTML     35K 
41: R27         Income Taxes (Tables)                               HTML     39K 
42: R28         Earnings Per Share (Tables)                         HTML     31K 
43: R29         Segment and Geographic Information (Tables)         HTML     44K 
44: R30         Fair Value (Tables)                                 HTML    117K 
45: R31         Marketable Securities (Tables)                      HTML     47K 
46: R32         Inventories - Schedule of Inventories (Detail)      HTML     29K 
47: R33         Other Assets (Details)                              HTML     26K 
48: R34         Goodwill and Intangible Assets - Additional         HTML     25K 
                Information (Detail)                                             
49: R35         Goodwill and Intangible Assets - Intangible Assets  HTML     57K 
                (Detail)                                                         
50: R36         Accrued Liabilities - Summary of Accrued            HTML     41K 
                Liabilities (Detail)                                             
51: R37         Long Term Debt - Additional Information (Detail)    HTML     74K 
52: R38         Income Taxes - Components of Income Tax             HTML     40K 
                Expense/(Benefit) (Detail)                                       
53: R39         Income Taxes - Additional Information (Detail)      HTML     22K 
54: R40         Share-Based Compensation (Details)                  HTML     36K 
55: R41         Earnings Per Share - Reconciliation of Basic to     HTML     32K 
                Diluted Weighted-Average Shares Outstanding                      
                (Detail)                                                         
56: R42         Segment and Geographic Information - Additional     HTML     22K 
                Information (Detail)                                             
57: R43         Segment and Geographic Information - Summary of     HTML     31K 
                Net Sales by Product Category (Detail)                           
58: R44         Segment and Geographic Information - Summary of     HTML     31K 
                Net Sales by Geographic Area (Detail)                            
59: R45         Fair Value - Additional Information (Detail)        HTML     21K 
60: R46         Fair Value - Fair Value of Assets and Liabilities   HTML     52K 
                Measured on a Recurring Basis (Detail)                           
61: R47         Fair Value - Fair Value Measurements Using          HTML     41K 
                Significant Unobservable Inputs (Detail)                         
62: R48         Fair Value - Summary Showing the Recurring Fair     HTML     50K 
                Value Measurements of the Contingent Consideration               
                Liability (Detail)                                               
63: R49         Marketable Securities - Additional Information      HTML     24K 
                (Detail)                                                         
64: R50         Marketable Securities - Marketable Securities       HTML     34K 
                (Detail)                                                         
65: R51         Commitments and Continfencies - Additional          HTML     58K 
                Information (Detail)                                             
66: R52         Recently Issued Accounting Pronouncements           HTML     28K 
                (Details)                                                        
67: R53         Restructuring - Additional Information (Detail)     HTML     26K 
69: XML         IDEA XML File -- Filing Summary                      XML    117K 
68: EXCEL       IDEA Workbook of Financial Reports                  XLSX     63K 
 9: EX-101.INS  XBRL Instance -- ango-20160831                       XML   1.19M 
11: EX-101.CAL  XBRL Calculations -- ango-20160831_cal               XML    183K 
12: EX-101.DEF  XBRL Definitions -- ango-20160831_def                XML    358K 
13: EX-101.LAB  XBRL Labels -- ango-20160831_lab                     XML   1.13M 
14: EX-101.PRE  XBRL Presentations -- ango-20160831_pre              XML    625K 
10: EX-101.SCH  XBRL Schema -- ango-20160831                         XSD    130K 
70: ZIP         XBRL Zipped Folder -- 0001275187-16-000037-xbrl      Zip    143K 


‘R47’   —   Fair Value – Fair Value Measurements Using Significant Unobservable Inputs (Detail)


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v3.5.0.2
Fair Value - Fair Value Measurements Using Significant Unobservable Inputs (Detail)
$ in Thousands
3 Months Ended
USD ($)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]  
Financial assets, begining balance $ 1,653
Included in other comprehensive income, assets (6)
Contingent consideration - Clinical Devices, assets 0
Financial assets, ending balance 1,647
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]  
Financial liabilities, begining balance 38,275
Change in Fair Value of Contingent Consideration 443
Included in other comprehensive income, liabilities 0
Financial liabilities, ending balance 36,618
Clinical Devices B.V [Member]  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]  
Contingent consideration - Clinical Devices, liabilities $ (2,100)

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:10/5/168-K
For Period end:8/31/1610-Q/A,  4
 List all Filings 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/03/23  Angiodynamics Inc.                10-K        5/31/23  112:11M                                    Workiva Inc Wde… FA01/FA
 7/22/22  Angiodynamics Inc.                10-K        5/31/22  106:11M
 7/27/21  Angiodynamics Inc.                10-K        5/31/21  110:11M
 8/10/20  Angiodynamics Inc.                10-K        5/31/20  118:15M
Top
Filing Submission 0001275187-16-000037   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 10, 3:37:00.1pm ET